Digitala Vetenskapliga Arkivet

Endre søk
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
From neuroscience to evidence based psychological treatments - The promise and the challenge, ECNP March 2016, Nice, France
Univ Oxford, Univ Dept Psychiat, Oxford OX3 7JX, England.;Warneford Hosp, Oxford Hlth NHS Trust, Oxford OX3 7JX, England..
Karolinska Inst, Dept Clin Neurosci, SE-17177 Stockholm, Sweden..ORCID-id: 0000-0001-7319-3112
Karolinska Inst, Dept Clin Neurosci, SE-17177 Stockholm, Sweden..
Univ Oxford, Univ Dept Psychiat, Oxford OX3 7JX, England.;Warneford Hosp, Oxford Hlth NHS Trust, Oxford OX3 7JX, England..
Vise andre og tillknytning
2018 (engelsk)Inngår i: European Neuropsychopharmacology, ISSN 0924-977X, E-ISSN 1873-7862, Vol. 28, nr 2, s. 317-333Artikkel i tidsskrift (Fagfellevurdert) Published
Abstract [en]

This ECNP meeting was designed to build bridges between different constituencies of mental illness treatment researchers from a range of backgrounds with a specific focus on enhancing the development of novel, evidence based, psychological treatments. In particular we wished to explore the potential for basic neuroscience to support the development of more effective psychological treatments, just as this approach is starting to illuminate the actions of drugs. To fulfil this aim, a selection of clinical psychologists, psychiatrists and neuroscientists were invited to sit at the same table. The starting point of the meeting was the proposition that we know certain psychological treatments work, but we have only an approximate understanding of why they work. The first task in developing a coherent mental health science would therefore be to uncover the mechanisms (at all levels of analysis) of effective psychological treatments. Delineating these mechanisms, a task that will require input from both the clinic and the laboratory, will provide a key foundation for the rational optimisation of psychological treatments. As reviewed in this paper, the speakers at the meeting reviewed recent advances in the understanding of clinical and cognitive psychology, neuroscience, experimental psychopathology, and treatment delivery technology focussed primarily on anxiety disorders and depression. We started by asking three rhetorical questions: What has psychology done for treatment? What has technology done for psychology? What has neuroscience done for psychology? We then addressed how research in five broad research areas could inform the future development of better treatments: Attention, Conditioning, Compulsions and addiction, Emotional Memory, and Reward and emotional bias. Research in all these areas (and more) can be harnessed to neuroscience since psychological therapies are a learning process with a biological basis in the brain. Because current treatment approaches are not fully satisfactory, there is an imperative to understand why not. And when psychological therapies do work we need to understand why this is the case, and how we can improve them. We may be able to improve accessibility to treatment without understanding mechanisms. But for treatment innovation and improvement, mechanistic insights may actually help. Applying neuroscience in this way will become an additional mission for ECNP.

sted, utgiver, år, opplag, sider
ELSEVIER SCIENCE BV , 2018. Vol. 28, nr 2, s. 317-333
Emneord [en]
Neuroscience, Cognitive Behaviour Therapy (CBT), Anxiety, Fear conditioning, Research Domain Criteria (RDoC)
HSV kategori
Identifikatorer
URN: urn:nbn:se:uu:diva-349835DOI: 10.1016/j.euroneuro.2017.10.036ISI: 000424840100009PubMedID: 29371024OAI: oai:DiVA.org:uu-349835DiVA, id: diva2:1204136
Forskningsfinansiär
The Karolinska Institutet's Research FoundationEU, Horizon 2020, 705641Tilgjengelig fra: 2018-05-07 Laget: 2018-05-07 Sist oppdatert: 2022-10-28bibliografisk kontrollert

Open Access i DiVA

fulltext(647 kB)603 nedlastinger
Filinformasjon
Fil FULLTEXT01.pdfFilstørrelse 647 kBChecksum SHA-512
9fcd4c225991abfbbe38d1549b950e3014d2baf6aa6727ea01b1ea98f21304344b1e40828e74e9be6271bdd90e821c09caf61ae52fc15279ea8bf9c4a6dc653f
Type fulltextMimetype application/pdf

Andre lenker

Forlagets fulltekstPubMed

Søk i DiVA

Av forfatter/redaktør
Holmes, Emily A.Månsson, Kristoffer N.T.
Av organisasjonen
I samme tidsskrift
European Neuropsychopharmacology

Søk utenfor DiVA

GoogleGoogle Scholar
Totalt: 603 nedlastinger
Antall nedlastinger er summen av alle nedlastinger av alle fulltekster. Det kan for eksempel være tidligere versjoner som er ikke lenger tilgjengelige

doi
pubmed
urn-nbn

Altmetric

doi
pubmed
urn-nbn
Totalt: 228 treff
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf